Epidemiologic association of Chlamydia pneumoniae and atherosclerosis: The initial serologic observation and more

Journal of Infectious Diseases

Volumn 181, Issue 6 SUPPL. 3, 2000, Pages

  Saikku, Pekka ^a,b  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b UNIVERSITY OF OULU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; BACTERIUM LIPOPOLYSACCHARIDE; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY;

ACUTE HEART INFARCTION; ANTIBODY TITER; ANTIGEN ANTIBODY COMPLEX; ATHEROSCLEROSIS; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CONFERENCE PAPER; DISEASE ASSOCIATION; HUMAN; PRIORITY JOURNAL; RISK FACTOR; SEROCONVERSION;

EID: 0034053702     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315625     Document Type: Conference Paper

References (21)

1. 1. Nieto JF. Infections and atherosclerosis: new clues from an old hypothesis. Am J Epidemiol 1998;148:937-48.
2. 2. May J. La intradermoreaccion de Frei en las arteropatias. Rev Argentina Dermatosifil 1943;27:581-2.
3. 3. Ambrosetti QFE. La reaccion de Frei en las endoarteritis obliterantes. Rev Argentina Dermatosifil 1943;27:624-5.
4. 4. Coutts WE, Davila M. Lymphogranuloma venereum as a possible cause of arterio-sclerosis and other arterial conditions. J Trop Med Hyg 1945;48: 46-51.
5. 5. Mattila K. Viral and bacterial infections in acute myocardial infarction. J Intern Med 1989;225:293-6.
6. 6. Nurminen M, Leinonen M, Saikku P, Mäkelä PH. The genus-specific antigen of Chlamydia: resemblance to the lipopolysaccharide of enteric bacteria. Science 1983;220:1279-81.
7. 7. Brade H, Brade L, Nano FE. Chemical and serological investigations on the genus-specific lipopolysaccharide epitope of Chlamydia. Proc Natl Acad Sci USA 1987;84:508-12.
8. 8. Saikku P, Leinonen M, Mattila K, et al. Serologic evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 1988;2:983-5.
9. 9. Leinonen M, Saikku P, Ekman MR, et al. Demonstration of antibody responses to Re-lipopolysaccharide as a diagnostic tool for chlamydial pneumonia. In: Proceedings of the First Conference of the European Society for Chlamydial Research. Stockholm: Almqvist & Wiksell International, 1988:269.
10. 10. Ekman MR, Leinonen M, Syrjälä H, et al. Evaluation of serological methods in the diagnosis of Chlamydia pneumoniae pneumonia during an epidemic in Finland. Eur J Clin Microbiol Infect Dis 1993;12:756-60.
11. 11. Darougar S, Forsey T, Brewerton DA, Rogers KL. Prevalence of antichlamydial antibodies in London blood donors. Br J Vener Dis 1980;56:404-7.
12. 12. Wang SP, Grayston JT. Population prevalence antibody to Chlamydia pneumoniae, strain TWAR. In: Proceedings of the 7th International Symposium on Human Chlamydial Infections, Harrison Hot Springs, Canada. 1990: 402-5.
13. 13. Leinonen M. Chlamydia pneumoniae and its epidemiology. Eur Heart J 1993;14(suppl K):57-61.
14. 14. Karvonen M, Tuomilchto J, Pitkänicmi J, Saikku P. The epidemic cycle of Chlamydia pneumoniae infection in eastern Finland between the years 1972 and 1987. Epidem Infect 1993;110:349-60: [erratum] 1993;111:567.
15. 15. Versey JMB, Gabriel R. Soluble-complex formation after myocardial infarction. Lancet 1974;2:493-4.
16. 16. Smith GW, McArthur CJ, Simpson IJ. Circulating immune complexes in myocardial infarction. J Clin Lab Immunol 1983;12:197-9.
17. 17. Leinonen M, Linnanmäki E, Mattila K, et al. Circulating immune complexes containing chlamydial lipopolysaccharide in acute myocardial infarction. Microb Pathog 1990;9:67-73.
18. 18. Linnanmäki E, Leinonen M, Mattila K, et al. Presence of Chlamydia pneumoniae specific antibodies in circulating immune complexes in coronary heart disease. Circulation 1993;87:1130-4.
19. 19. Frick MH, Elo O, Haapa K, et al. Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med 1987;317:1237-45.
20. 20. Saikku P, Leinonen M, Tenkanen L, et al. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann Intern Med 1992;116:273-8.
21. 21. Tiran A, Tio RA, Ossewaarde JM, et al. Coronary angioplasty induces rise in Chlamydia pneumoniae specific antibodies. J Clin Microbiol 1999;37: 1013-7.